TSP1 has higher bioavailability to activate TGFβ ligands in the ECM of RDEB patients since binding between C7 and TSP1 prevents TSP1 from activating the TGFβ pathway [23]. The gene discussed is TGFB1; the disease is recessive dystrophic epidermolysis bullosa.